Cargando…

c-Met: A Promising Therapeutic Target in Bladder Cancer

Mesenchymal-epithelial transition factor (c-Met) belongs to the tyrosine kinase receptor family and is overexpressed in various human cancers. Its ligand is hepatocyte growth factor (HGF), and the HGF/c-Met signaling pathway is involved in a wide range of cellular processes, including cell prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yanfei, Yang, Zitong, Xu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374328/ https://www.ncbi.nlm.nih.gov/pubmed/35967753 http://dx.doi.org/10.2147/CMAR.S369175

Ejemplares similares

HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
por: Zhang, Hongli, et al.
Publicado: (2018)

MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review
por: Terlecka, Paulina, et al.
Publicado: (2021)

EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015)

Androgen receptor in bladder cancer: A promising therapeutic target
por: Tripathi, Abhishek, et al.
Publicado: (2020)

The Diagnostic and Therapeutic Role of Circular RNA HIPK3 in Human Diseases
por: Feng, Yanfei, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
por: Wang, Hao, et al.
Publicado: (2023)

Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
por: Kim, Hyun Jung
Publicado: (2022)

Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020)

Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma
por: Bouattour, Mohamed, et al.
Publicado: (2018)

miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer
por: Cai, Zhonglin, et al.
Publicado: (2019)

Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets
por: Chang, Katherine, et al.
Publicado: (2015)

The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
por: Hu, Chi-Tan, et al.
Publicado: (2017)

Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer
por: Zhu, Zhaowei, et al.
Publicado: (2012)

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
por: Liang, Hongge, et al.
Publicado: (2020)

Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
por: Zhao, Xixi, et al.
Publicado: (2017)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)

Targeting KRAS in Cancer: Promising Therapeutic Strategies
por: Mustachio, Lisa Maria, et al.
Publicado: (2021)

Clinicopathological impacts of c-Met overexpression in bladder cancer: evidence from 1,336 cases
por: Xu, Xin, et al.
Publicado: (2019)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target
por: Faiella, Antonio, et al.
Publicado: (2022)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches
por: Kumaki, Yuichi, et al.
Publicado: (2023)

miRNA: A Promising Therapeutic Target in Cancer
por: Menon, Amrutha, et al.
Publicado: (2022)

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
por: Trovato, Maria, et al.
Publicado: (2017)

ACE2, a promising therapeutic target for pulmonary hypertension
por: Shenoy, Vinayak, et al.
Publicado: (2011)

Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment
por: Zhang, Yilong, et al.
Publicado: (2015)

Interplay between Exosomes and Autophagy in Cardiovascular Diseases: Novel Promising Target for Diagnostic and Therapeutic Application
por: Tian, Jinfan, et al.
Publicado: (2019)

Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer
por: Necula, Laura, et al.
Publicado: (2022)

RNA-binding protein 39: a promising therapeutic target for cancer
por: Xu, Caipeng, et al.
Publicado: (2021)

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer
por: Sun, Dantong, et al.
Publicado: (2023)

Development of antibody-based c-Met inhibitors for targeted cancer therapy
por: Lee, Dongheon, et al.
Publicado: (2015)

Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer
por: Miranda, Oshin, et al.
Publicado: (2018)

The Cellular Prion Protein: A Promising Therapeutic Target for Cancer
por: Go, Gyeongyun, et al.
Publicado: (2020)

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
por: Sui, X, et al.
Publicado: (2013)

The Promise of Novel Molecular Markers in Bladder Cancer
por: Miremami, Jahan, et al.
Publicado: (2014)

DNA Methylation as a Therapeutic Target for Bladder Cancer
por: Nunes, Sandra P., et al.
Publicado: (2020)

Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
por: Liu, Guoqiang, et al.
Publicado: (2023)

c-Met and miRs in Cancer
por: Giglio, Simona, et al.
Publicado: (2015)

P-TEFb as A Promising Therapeutic Target
por: Fujinaga, Koh
Publicado: (2020)

Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?
por: Cosín-Roger, Jesús, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7jtt55df5o98eapbuo2glth0da